No article text was recorded for this version.
gender-based pharmacovigilance
Version 1 of 138 papers56 conceptsfrozen 2026-10-04
Papers in this version
- Blog: Navigating the complex landscape of benzodiazepine- and Z-drug diversity: insights from comprehensive FDA adverse event reporting system analysis and beyond
- Blog: Acute and subacute oral toxicity assessment of Gancao Xiexin decoction in Sprague-Dawley rats
- Blog: Investigating safety profiles of human papillomavirus vaccine across group differences using VAERS data and MedDRA
- Blog: Trivalent Influenza Vaccine Adverse Event Analysis Based On MedDRA System Organ Classes Using VAERS Data
- Blog: Safety of antidepressants commonly used in 6–17-year-old children and adolescents: A disproportionality analysis from 2014–2023 on the basis of the FAERS database
- Blog: Large-scale in silico identification of drugs exerting sex-specific effects in the heart
- Blog: Comprehensive safety assessment of donepezil: pharmacovigilance analysis based on the FDA adverse event reporting system
- Blog: Population-scale identification of differential adverse events before and during a pandemic
- Blog: Evaluation of pitolisant, sodium oxybate, solriamfetol, and modafinil for the management of narcolepsy: a retrospective analysis of the FAERS database
- Blog: Prenatal exposure to metal mixture and sex-specific birth outcomes in the New Hampshire Birth Cohort Study
- Blog: Trivalent influenza vaccine adverse symptoms analysis based on MedDRA terminology using VAERS data in 2011
- Blog: CSF1R inhibitors induce a sex-specific resilient microglial phenotype and functional rescue in a tauopathy mouse model
- Blog: Incidence of Side Effects During Tenofovir Alafenamide Monotherapy in Patients with Chronic Hepatitis B
- Blog: Characterization of the Differential Adverse Event Rates by Race/Ethnicity Groups for HPV Vaccine by Integrating Data From Different Sources
- Blog: Neurons and glial cells acquire a senescent signature after repeated mild traumatic brain injury in a sex-dependent manner
- Blog: Pharmacovigilance study on old drugs repurposed for rare diseases across different indications: the case of fenfluramine
- Blog: Maternal paraben exposure triggers childhood overweight development
- Blog: Acute and Subchronic Oral Toxicity of Anthraquinone in Sprague Dawley Rats
- Blog: A Real‐World Pharmacovigilance Study of Fruquintinib Based on the <scp>FDA</scp> Adverse Event Reporting System ( <scp>FAERS</scp> ) Database
- Blog: Resveratrol Butyrate Esters Inhibit Obesity Caused by Perinatal Exposure to Bisphenol A in Female Offspring Rats
- Blog: Adverse drug events (ADEs) risk signal mining related to eculizumab based on the FARES database
- Blog: Iodine-Induced Hyperthyroidism and Long-term Risks of Incident Atrial Fibrillation and Flutter
- Blog: Long-term ambient hydrocarbons exposure and incidence of ischemic stroke
- Blog: Drug-associated serotonin syndrome in elderly patients: a comprehensive disproportionality analysis based on the FAERS database
- Blog: External exposome and incident asthma across the life course in 14 European cohorts: a prospective analysis within the EXPANSE project
- Blog: Combination of Deep Recurrent Neural Networks and Conditional Random Fields for Extracting Adverse Drug Reactions from User Reviews
- Blog: Prenatal chromium exposure and risk of preterm birth: a cohort study in Hubei, China
- Blog: The association between outdoor air pollution and lung cancer risk in seven eastern metropolises of China: Trends in 2006-2014 and sex differences
- Blog: Detecting drug-drug interactions between therapies for COVID-19 and concomitant medications through the FDA adverse event reporting system
- Blog: Precision Adverse Drug Reactions Prediction with Heterogeneous Graph Neural Network
- Blog: A real-world pharmacovigilance study of omalizumab using disproportionality analysis in the FDA adverse drug events reporting system database
- Blog: Clarity AD: Asian regional analysis of a phase III trial of lecanemab in early Alzheimer's disease
- Blog: A literature analysis on 14 cases of allergic shock caused by safflower injection
- Blog: The Relationship Between Daily Dietary Intake of Fiber and Short Sleep Duration in the Presence of Di(2-Ethylhexyl) Phthalate: A Population-Based Study
- Blog: Comparing drug safety of hepatitis C therapies using post-market data
- Blog: Phase I clinical trial of NH130 and the prediction of its pharmacokinetics using physiologically based pharmacokinetic modeling
- Blog: Adverse reactions and safety profile of the mRNA COVID-19 vaccines among Asian military personnel
- Blog: α-Blocker Use in Hemodialysis: The Japan Dialysis Outcomes and Practice Patterns Study
History & citation
Current · Permanent link
- Demographic Specificity in Adverse Drug Reaction Profiles merged into this direction (65% overlap)
Cite this direction
Latest version (a living page):
@misc{lacuna_gender_based_pharmacovigilance_81c83731,
title = {gender-based pharmacovigilance},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/gender-based-pharmacovigilance/rdr_81c8373199ab4b23bb11376163c42856},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-21},
}This exact version (version 1, frozen text):
@misc{lacuna_gender_based_pharmacovigilance_81c83731_v1,
title = {gender-based pharmacovigilance},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/gender-based-pharmacovigilance/rdr_81c8373199ab4b23bb11376163c42856/v/1},
note = {Version 1, frozen 2026-10-04. Accessed 2026-11-21},
}